Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
touchIN CONVERSATION for touchRESPIRATORY
Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations.
In Part 1 they respond to questions from the oncology and respiratory clinical communities on:
Biomarker testing in advanced NSCLC
Identifying patients with METex14 skipping mutations
Targeting METex14 skipping mutations
In Part 2, they respond to questions from the oncology and respiratory clinical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.